[
  {
    "publication_date": "2026-06-09",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "Christine Elizabeth Rankin",
    "person_in_leading_position": "Christine Elizabeth Rankin",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "Ja",
    "character": "Tilldelning",
    "category": "other",
    "instrument_type": "Aktie",
    "instrument_name": "Oncopeptides AB",
    "isin": "SE0009414576",
    "transaction_date": "2026-06-09",
    "volume": 59897.0,
    "volume_raw": "59897,0",
    "volume_unit": "Antal",
    "price": 0.0,
    "price_raw": "0,0",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 0.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-06-09",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "Per Wold-Olsen",
    "person_in_leading_position": "Per Wold-Olsen",
    "position": "Styrelseordförande",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "Ja",
    "character": "Tilldelning",
    "category": "other",
    "instrument_type": "Aktie",
    "instrument_name": "Ordinary Share (ONCO)",
    "isin": "SE0009414576",
    "transaction_date": "2026-06-09",
    "volume": 149743.0,
    "volume_raw": "149743,0",
    "volume_unit": "Antal",
    "price": 0.0,
    "price_raw": "0,0",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 0.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-03-20",
    "issuer": "Oncopeptides AB (publ)",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "Stefan Norin",
    "person_in_leading_position": "Stefan Norin",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Tilldelning",
    "category": "other",
    "instrument_type": "Aktie",
    "instrument_name": "Oncopeptides",
    "isin": "SE0009414576",
    "transaction_date": "2026-03-19",
    "volume": 3000.0,
    "volume_raw": "3000,0",
    "volume_unit": "Antal",
    "price": 1.55,
    "price_raw": "1,55",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 4650.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-03-18",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "Christine Elizabeth Rankin",
    "person_in_leading_position": "Christine Elizabeth Rankin",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Oncopeptides AB",
    "isin": "SE0009414576",
    "transaction_date": "2026-03-17",
    "volume": 14631.0,
    "volume_raw": "14631,0",
    "volume_unit": "Antal",
    "price": 1.625,
    "price_raw": "1,625",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 23775.375,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-03-17",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "Per Wold-Olsen",
    "person_in_leading_position": "Per Wold-Olsen",
    "position": "Styrelseordförande",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Oncopeptides BTA",
    "isin": "SE0021924370",
    "transaction_date": "2026-03-17",
    "volume": 418876.0,
    "volume_raw": "418876,0",
    "volume_unit": "Antal",
    "price": 1.55,
    "price_raw": "1,55",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 649257.8,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-03-17",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "Sofia Heigis",
    "person_in_leading_position": "Sofia Heigis",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Oncopeptides BTA",
    "isin": "SE0027999608",
    "transaction_date": "2026-03-17",
    "volume": 87833.0,
    "volume_raw": "87833,0",
    "volume_unit": "Antal",
    "price": 1.55,
    "price_raw": "1,55",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 136141.15,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-03-17",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "David Augustsson",
    "person_in_leading_position": "David Augustsson",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Oncopeptides BTA",
    "isin": "SE0027999608",
    "transaction_date": "2026-03-17",
    "volume": 1070.0,
    "volume_raw": "1070,0",
    "volume_unit": "Antal",
    "price": 1.53,
    "price_raw": "1,53",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 1637.1000000000001,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-03-17",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "David Augustsson",
    "person_in_leading_position": "David Augustsson",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Oncopeptides BTA",
    "isin": "SE0027999608",
    "transaction_date": "2026-03-17",
    "volume": 4681.0,
    "volume_raw": "4681,0",
    "volume_unit": "Antal",
    "price": 1.53,
    "price_raw": "1,53",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 7161.93,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-03-17",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "David Augustsson",
    "person_in_leading_position": "David Augustsson",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Oncopeptides BTA",
    "isin": "SE0027999608",
    "transaction_date": "2026-03-17",
    "volume": 6756.0,
    "volume_raw": "6756,0",
    "volume_unit": "Antal",
    "price": 1.53,
    "price_raw": "1,53",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 10336.68,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-03-17",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "David Augustsson",
    "person_in_leading_position": "David Augustsson",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Oncopeptides BTA",
    "isin": "SE0027999608",
    "transaction_date": "2026-03-17",
    "volume": 1872.0,
    "volume_raw": "1872,0",
    "volume_unit": "Antal",
    "price": 1.53,
    "price_raw": "1,53",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 2864.16,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-03-17",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "Eva Sabina Marianne Nordström",
    "person_in_leading_position": "Eva Sabina Marianne Nordström",
    "position": "Vice VD",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "ONCO BTA",
    "isin": "SE0027999608",
    "transaction_date": "2026-03-16",
    "volume": 140232.0,
    "volume_raw": "140232,0",
    "volume_unit": "Antal",
    "price": 1.55,
    "price_raw": "1,55",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 217359.6,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-03-17",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "David Augustsson",
    "person_in_leading_position": "David Augustsson",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Tilldelning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Oncopeptides BTA",
    "isin": "SE0027999608",
    "transaction_date": "2026-03-16",
    "volume": 456.0,
    "volume_raw": "456,0",
    "volume_unit": "Antal",
    "price": 1.55,
    "price_raw": "1,55",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 706.8000000000001,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-03-17",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "David Augustsson",
    "person_in_leading_position": "David Augustsson",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Tilldelning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Oncopeptides BTA",
    "isin": "SE0027999608",
    "transaction_date": "2026-03-16",
    "volume": 66.0,
    "volume_raw": "66,0",
    "volume_unit": "Antal",
    "price": 1.55,
    "price_raw": "1,55",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 102.3,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-03-17",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "Henrik Bergentoft",
    "person_in_leading_position": "Henrik Bergentoft",
    "position": "Ekonomichef/finanschef/finansdirektör",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Oncopeptides AB BTA",
    "isin": "SE0027999608",
    "transaction_date": "2026-03-16",
    "volume": 14258.0,
    "volume_raw": "14258,0",
    "volume_unit": "Antal",
    "price": 1.55,
    "price_raw": "1,55",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 22099.9,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-03-16",
    "issuer": "Oncopeptides AB (publ).",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "Stefan Norin",
    "person_in_leading_position": "Stefan Norin",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Oncopeptides BTA",
    "isin": "SE0027999608",
    "transaction_date": "2026-03-16",
    "volume": 6266.0,
    "volume_raw": "6266,0",
    "volume_unit": "Antal",
    "price": 1.55,
    "price_raw": "1,55",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 9712.300000000001,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-10-17",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "Per Wold-Olsen",
    "person_in_leading_position": "Per Wold-Olsen",
    "position": "Styrelseordförande",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "Ja",
    "character": "Tilldelning",
    "category": "other",
    "instrument_type": "Aktie",
    "instrument_name": "Ordinary share (ONCO)",
    "isin": "SE0009414576",
    "transaction_date": "2025-10-17",
    "volume": 254311.0,
    "volume_raw": "254311,0",
    "volume_unit": "Antal",
    "price": 0.0,
    "price_raw": "0,0",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 0.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-19",
    "issuer": "Oncopeptides AB (publ)",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "Stefan Norin",
    "person_in_leading_position": "Stefan Norin",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Tilldelning",
    "category": "other",
    "instrument_type": "Aktie",
    "instrument_name": "Oncopeptides",
    "isin": "SE0009414576",
    "transaction_date": "2025-09-17",
    "volume": 723.0,
    "volume_raw": "723,0",
    "volume_unit": "Antal",
    "price": 3.2,
    "price_raw": "3,20",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 2313.6,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-17",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "Per Wold-Olsen",
    "person_in_leading_position": "Per Wold-Olsen",
    "position": "Styrelseordförande",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Oncopeptides BTA",
    "isin": "SE0021924370",
    "transaction_date": "2025-09-17",
    "volume": 146362.0,
    "volume_raw": "146362,0",
    "volume_unit": "Antal",
    "price": 3.2,
    "price_raw": "3,20",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 468358.4,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-16",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "Per Wold-Olsen",
    "person_in_leading_position": "Per Wold-Olsen",
    "position": "Styrelseordförande",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "BTA",
    "isin": "SE0021924370",
    "transaction_date": "2025-09-16",
    "volume": 79590.0,
    "volume_raw": "79590,0",
    "volume_unit": "Antal",
    "price": 3.2,
    "price_raw": "3,20",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 254688.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-16",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "Henrik Bergentoft",
    "person_in_leading_position": "Henrik Bergentoft",
    "position": "Ekonomichef/finanschef/finansdirektör",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "BTA",
    "isin": "SE0026141947",
    "transaction_date": "2025-09-16",
    "volume": 5184.0,
    "volume_raw": "5184,0",
    "volume_unit": "Antal",
    "price": 3.2,
    "price_raw": "3,2",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 16588.8,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-16",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "David Augustsson",
    "person_in_leading_position": "David Augustsson",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Oncopeptides AB BTA",
    "isin": "SE0026141947",
    "transaction_date": "2025-09-15",
    "volume": 222.0,
    "volume_raw": "222,0",
    "volume_unit": "Antal",
    "price": 3.2,
    "price_raw": "3,20",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 710.4000000000001,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-16",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "David Augustsson",
    "person_in_leading_position": "David Augustsson",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Oncopeptides AB BTA",
    "isin": "SE0026141947",
    "transaction_date": "2025-09-15",
    "volume": 4628.0,
    "volume_raw": "4628,0",
    "volume_unit": "Antal",
    "price": 3.2,
    "price_raw": "3,2",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 14809.6,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-16",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "Sofia Heigis",
    "person_in_leading_position": "Sofia Heigis",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Oncopeptides AB BTA",
    "isin": "SE0026141947",
    "transaction_date": "2025-09-15",
    "volume": 12626.0,
    "volume_raw": "12626,0",
    "volume_unit": "Antal",
    "price": 3.2,
    "price_raw": "3,20",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 40403.200000000004,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-16",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "Sofia Heigis",
    "person_in_leading_position": "Sofia Heigis",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Oncopeptides AB BTA",
    "isin": "SE0026141947",
    "transaction_date": "2025-09-15",
    "volume": 19312.0,
    "volume_raw": "19312,0",
    "volume_unit": "Antal",
    "price": 3.2,
    "price_raw": "3,20",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 61798.4,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-15",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "Christine Elizabeth Rankin",
    "person_in_leading_position": "Christine Elizabeth Rankin",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Aktie",
    "isin": "SE0009414576",
    "transaction_date": "2025-09-15",
    "volume": 5320.0,
    "volume_raw": "5320,0",
    "volume_unit": "Antal",
    "price": 3.2,
    "price_raw": "3,20",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 17024.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-15",
    "issuer": "Oncopeptides AB (publ).",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "Stefan Norin",
    "person_in_leading_position": "Stefan Norin",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Oncopeptides BTA",
    "isin": "SE0026141947",
    "transaction_date": "2025-09-15",
    "volume": 2146.0,
    "volume_raw": "2146,0",
    "volume_unit": "Antal",
    "price": 3.2,
    "price_raw": "3,20",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 6867.200000000001,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-08-27",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "David Augustsson",
    "person_in_leading_position": "David Augustsson",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Oncopeptides AB",
    "isin": "SE0009414576",
    "transaction_date": "2025-08-26",
    "volume": 1000.0,
    "volume_raw": "1000,0",
    "volume_unit": "Antal",
    "price": 4.77,
    "price_raw": "4,77",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 4770.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-08-27",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "David Augustsson",
    "person_in_leading_position": "David Augustsson",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Oncopeptides AB",
    "isin": "SE0009414576",
    "transaction_date": "2025-08-26",
    "volume": 1000.0,
    "volume_raw": "1000,0",
    "volume_unit": "Antal",
    "price": 4.775,
    "price_raw": "4,775",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 4775.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-08-26",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "Sofia Heigis",
    "person_in_leading_position": "Sofia Heigis",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Oncopeptides AB",
    "isin": "SE0009414576",
    "transaction_date": "2025-08-26",
    "volume": 56820.0,
    "volume_raw": "56820,0",
    "volume_unit": "Antal",
    "price": 4.4,
    "price_raw": "4,4",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 250008.00000000003,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-08-25",
    "issuer": "Oncopeptides AB",
    "lei": "549300J9WWQ5CBYQ1M77",
    "reporting_person": "David Augustsson",
    "person_in_leading_position": "David Augustsson",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Oncopeptides AB",
    "isin": "SE0009414576",
    "transaction_date": "2025-08-25",
    "volume": 3500.0,
    "volume_raw": "3500,0",
    "volume_unit": "Antal",
    "price": 4.38,
    "price_raw": "4,38",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 15330.0,
    "status": "Aktuell",
    "is_current_report": true
  }
]